Novavax announces 90% efficacy of covid vaccine

Novavax has announced on Monday the results of a clinical trial of its Covid-19 vaccine in the United States and Mexico, finding that its two-shot inoculation provides potent protection against the coronavirus, reaching the 90%, and 100% preventing moderate or severe illnesses.